SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-045822
Filing Date
2019-08-13
Accepted
2019-08-13 19:57:29
Documents
1
Period of Report
2019-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14343
  Complete submission text file 0001209191-19-045822.txt   15814
Mailing Address C/O DECIPHERA PHARMACEUTICALS, LLC 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address
Taylor Michael Douglas (Reporting) CIK: 0001494875 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38219 | Film No.: 191022419

Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1